Ranking Vaccines Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework (2015) / Chapter Skim
Currently Skimming:
Appendix A: Use Case Scenarios Report for SMART Vaccines
Appendix A: Use Case Scenarios Report for SMART Vaccines
Pages 85-92
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 85... ...
For SMART Vaccines specifically, the usefulness was already established before the Phase III project began. Thus, the purpose of these site visits at this stage was to formally understand the usability of SMART Vaccines from real decision makers.
|
From page 86... ...
User Scenarios and Key Interest Areas The three user groups were interested in using SMART Vaccines in the following scenarios: 1. Identifying new vaccine candidates and influencing their devel opment using an analytical system, which included the following features: • Transparency • he ability to facilitate discussions among provincial and T other organizational leaders • The potential to shorten the time to new product licensing • A better understanding of the value of lifelong immunizations • A lifelong reduction of disease burden • educe the current "piecemeal" approaches among stake R holders and help improve coordination among them
|
From page 87... ...
has an impact on desired public health goals • xamining differences in cost, efficacy, and other factors E between oral and injected vaccines • omparing the impact of vaccines requiring multiple doses C with the impact of single-dose vaccines • etermining whether certain ingredients will cause issues D with uptake (thimerosal, for example) Key Observations and Suggestions The following observations concern only the user studies conducted with the Public Health Agency of Canada, NYSDOH, and the Serum Institute of India.
|
From page 88... ...
2. Disease burden Specifically, the Minor The tool should either allow percentages problem occurred one or more decimal places appear to when one or more consistently or specify add up to decimal places the decimal place limit 100 percent, were in use, even for percentages or better but the tool if the percentages inform the user about still does not clearly added up the data entry needs.
|
From page 89... ...
special) applies only to disease the subpopulation data and vaccine information and that pertain only to the the SMART Scores are calculated specific disease and on the basis of the whole vaccine candidates under population.
|
From page 90... ...
However, it would be much more beneficial to have this as a quantitative entity rather than an attribute for prioritizing existing vaccines. It could be useful for new vaccine development as well because users may want to set the tolerance level.
|
From page 91... ...
11. Additional It is not clear how the data on The committee should clarity direct costs of vaccine use per consider offering required on year or incident cases prevented additional information data entry per year, for example, are through notes or needs.
|
From page 92... ...
The committee should review alternate scenarios, such as prioritizing existing vaccines, and study the user requirements to determine whether SMART Vaccines can be appropriately adjusted to effectively meet this task. Most of the remaining usability issues can be addressed with tool tips and call-outs to help the users understand what they are doing.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.